Literature DB >> 27712979

Novel polyacrylate-based cationic nanoparticles for survivin siRNA delivery combined with mitoxantrone for treatment of breast cancer.

Sanam Arami1, Majid Mahdavi2, Mohammad Reza Rashidi3, Marziyeh Fathi4, Mohammad-Saeid Hejazi5, Nasser Samadi6.   

Abstract

As a gene delivery method in breast cancer therapy, knocking down the undesired genes in the cancerous cells would be promising. Inhibitors of Apoptosis Protein (IAP) family genes are some of the genes whose responsibility is inhibition of apoptosis in cells. Silencing these genes seems to be helpful directing the tumor cells to death. siRNA sequence designed against survivin anti-apoptotic gene can play this role if carried to the cytoplasm. Here we prepared a positive charged biocompatible nano-sized particle made up of a Fe3O4 core covered respectively by polyacrylate (PA) and polyethyleneimine (PEI) layer, which could successfully deliver the siRNA into the MCF-7 cells. The particle structure was checked and having less than 50 nm diameter in size, positive charge and, safety towards MCF-7 cells besides being able to form nanoplexes with the siRNA strand helps it entering into the biologic assays part. The siRNA delivery evaluated via flowcytometry. Apoptosis induction was determined by DAPI staining. The efficiency of survivin gene knockdown was evaluated in mRNA and protein levels using Real time PCR and western blotting methods. Overall, the Fe3O4-PA-PEI nanoparticles can deliver siRNA effectively into the cytoplasm of the MCF-7 breast cancer cells and induce apoptosis.
Copyright © 2016 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cationic nanoparticle; Gene delivery; Polyacrylic acid; Survivin; siRNA

Mesh:

Substances:

Year:  2016        PMID: 27712979     DOI: 10.1016/j.biologicals.2016.09.005

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  5 in total

Review 1.  Engineering the RNA-Nanobio Interface.

Authors:  Vaibhav Murthy; Robert K Delong
Journal:  Bioengineering (Basel)       Date:  2017-02-15

2.  Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer.

Authors:  Li Zhang; Xin Yang; Yaqi Lv; Xiaofei Xin; Chao Qin; Xiaopeng Han; Lei Yang; Wei He; Lifang Yin
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

3.  Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer.

Authors:  Yang Dong; Hongze Liao; Jian Yu; Hao Fu; Ke Gong; Qi Wang; Yourong Duan
Journal:  J Nanobiotechnology       Date:  2019-12-23       Impact factor: 10.435

4.  Dual-targeted lung cancer therapy via inhalation delivery of UCNP-siRNA-AS1411 nanocages.

Authors:  Yu Han; Yuming Yang; Qiuyang Sun; Bin Li; Caixia Yue; Yanlei Liu; Jesús M de la Fuente; Daxiang Cui
Journal:  Cancer Biol Med       Date:  2021-08-24       Impact factor: 5.347

5.  Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy.

Authors:  Zhen Yang; Juanli Duan; Jianlin Wang; Qi Liu; Runze Shang; Xisheng Yang; Peng Lu; Congcong Xia; Lin Wang; Kefeng Dou
Journal:  Int J Nanomedicine       Date:  2018-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.